ITMI960277A0 - - Google Patents
Info
- Publication number
- ITMI960277A0 ITMI960277A0 ITMI960277A ITMI960277A ITMI960277A0 IT MI960277 A0 ITMI960277 A0 IT MI960277A0 IT MI960277 A ITMI960277 A IT MI960277A IT MI960277 A ITMI960277 A IT MI960277A IT MI960277 A0 ITMI960277 A0 IT MI960277A0
- Authority
- IT
- Italy
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Hydrogenated Pyridines (AREA)
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT96MI000277A IT1282625B1 (it) | 1996-02-14 | 1996-02-14 | Composizione farmaceutica atta ad inibire la formazione di metastasi tumorali |
| EP97903257A EP0885006B1 (en) | 1996-02-14 | 1997-02-12 | Pharmaceutical composition enabling to inhibit cancer metastasis formation containing n-acetyl-cysteine and doxorubicin |
| DE69730317T DE69730317D1 (de) | 1996-02-14 | 1997-02-12 | N-acetylcystein und boxonubicin enthaltende pharmazeutische zusammensetzung zur hemmung der krebsmetastasierung |
| JP9528974A JP2000504704A (ja) | 1996-02-14 | 1997-02-12 | Ｎ―アセチルシステインおよびドキソルビシンを含有し癌の転移形成を抑制しうる医薬組成物 |
| AT97903257T ATE273710T1 (de) | 1996-02-14 | 1997-02-12 | N-acetylcystein und boxonubicin enthaltende pharmazeutische zusammensetzung zur hemmung der krebsmetastasierung |
| CA002245863A CA2245863A1 (en) | 1996-02-14 | 1997-02-12 | Pharmaceutical composition enabling to inhibit cancer metastasis formation containing n-acetyl-cysteine and doxorubicin |
| PCT/EP1997/000627 WO1997029759A1 (en) | 1996-02-14 | 1997-02-12 | Pharmaceutical composition enabling to inhibit cancer metastasis formation containing n-acetyl-cysteine and doxorubicin |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT96MI000277A IT1282625B1 (it) | 1996-02-14 | 1996-02-14 | Composizione farmaceutica atta ad inibire la formazione di metastasi tumorali |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| ITMI960277A0 true ITMI960277A0 (cg-RX-API-DMAC7.html) | 1996-02-14 |
| ITMI960277A1 ITMI960277A1 (it) | 1997-08-14 |
| IT1282625B1 IT1282625B1 (it) | 1998-03-31 |
Family
ID=11373264
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT96MI000277A IT1282625B1 (it) | 1996-02-14 | 1996-02-14 | Composizione farmaceutica atta ad inibire la formazione di metastasi tumorali |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0885006B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2000504704A (cg-RX-API-DMAC7.html) |
| AT (1) | ATE273710T1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2245863A1 (cg-RX-API-DMAC7.html) |
| DE (1) | DE69730317D1 (cg-RX-API-DMAC7.html) |
| IT (1) | IT1282625B1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO1997029759A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19926154A1 (de) | 1999-06-09 | 2000-12-14 | Ktb Tumorforschungs Gmbh | Verfahren zur Herstellung einer injizierbaren Arzneimittelzubereitung |
| JP2008506750A (ja) * | 2004-07-22 | 2008-03-06 | ティオマトリックス・フォルシュンクス・ウント・べラートゥンクス・ゲーエムベーハー | チオール基を含む化合物の排出ポンプ抑制剤としての使用 |
| EP2152312B1 (en) | 2007-05-16 | 2014-12-31 | KTB Tumorforschungsgesellschaft mbH | Low-viscous anthracycline formulation |
| WO2011110838A2 (en) * | 2010-03-08 | 2011-09-15 | Procure Therapeutics Limited | Differentiation factor |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4331648A (en) * | 1979-12-05 | 1982-05-25 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | N-Acetyl-cysteine protects against cardiac damage from subsequently-administered cardio-toxic anthra-cycline in cancer therapy |
| US4873088A (en) * | 1983-09-06 | 1989-10-10 | Liposome Technology, Inc. | Liposome drug delivery method and composition |
-
1996
- 1996-02-14 IT IT96MI000277A patent/IT1282625B1/it active IP Right Grant
-
1997
- 1997-02-12 EP EP97903257A patent/EP0885006B1/en not_active Expired - Lifetime
- 1997-02-12 AT AT97903257T patent/ATE273710T1/de not_active IP Right Cessation
- 1997-02-12 DE DE69730317T patent/DE69730317D1/de not_active Expired - Lifetime
- 1997-02-12 CA CA002245863A patent/CA2245863A1/en not_active Abandoned
- 1997-02-12 JP JP9528974A patent/JP2000504704A/ja not_active Ceased
- 1997-02-12 WO PCT/EP1997/000627 patent/WO1997029759A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| ATE273710T1 (de) | 2004-09-15 |
| EP0885006B1 (en) | 2004-08-18 |
| ITMI960277A1 (it) | 1997-08-14 |
| WO1997029759A1 (en) | 1997-08-21 |
| IT1282625B1 (it) | 1998-03-31 |
| JP2000504704A (ja) | 2000-04-18 |
| CA2245863A1 (en) | 1997-08-21 |
| DE69730317D1 (de) | 2004-09-23 |
| EP0885006A1 (en) | 1998-12-23 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 0001 | Granted |